Search Results - "Lazarus, M"

Refine Results
  1. 1

    Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation by Cairo, Mitchell S., Cooke, Kenneth R., Lazarus, Hillard M., Chao, Nelson

    Published in British journal of haematology (01-09-2020)
    “…Summary Sinusoidal obstruction syndrome (SOS), previously known as hepatic veno‐occlusive disease (VOD), remains a multi‐organ system complication following…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved by Shallis, Rory M., Gale, Robert P., Lazarus, Hillard M., Roberts, Kenneth B., Xu, Mina L., Seropian, Stuart E., Gore, Steven D., Podoltsev, Nikolai A.

    Published in Blood reviews (01-05-2021)
    “…The World Health Organization classification and definition of “myeloid sarcoma” is imprecise and misleading. A more accurate term is “extramedullary acute…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation by Ueda, Masumi, Berger, Melvin, Gale, Robert Peter, Lazarus, Hillard M.

    Published in Blood reviews (01-03-2018)
    “…Immunoglobulins are used to prevent or reduce infection risk in primary immune deficiencies and in settings which exploit its anti-inflammatory and…”
    Get full text
    Journal Article
  8. 8

    Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens by Lazarus, Michael, Shen, Hai-Ying, Cherasse, Yoan, Qu, Wei-Min, Huang, Zhi-Li, Bass, Caroline E, Winsky-Sommerer, Raphaelle, Semba, Kazue, Fredholm, Bertil B, Boison, Detlev, Hayaishi, Osamu, Urade, Yoshihiro, Chen, Jiang-Fan

    Published in The Journal of neuroscience (06-07-2011)
    “…Caffeine, the most widely used psychoactive compound, is an adenosine receptor antagonist. It promotes wakefulness by blocking adenosine A(2A) receptors…”
    Get full text
    Journal Article
  9. 9

    Anthracycline Dose Intensification in Acute Myeloid Leukemia by Fernandez, Hugo F, Sun, Zhuoxin, Yao, Xiaopan, Litzow, Mark R, Luger, Selina M, Paietta, Elisabeth M, Racevskis, Janis, Dewald, Gordon W, Ketterling, Rhett P, Bennett, John M, Rowe, Jacob M, Lazarus, Hillard M, Tallman, Martin S

    Published in The New England journal of medicine (24-09-2009)
    “…Patients with AML who were between 17 and 60 years of age were randomly assigned to receive induction therapy with the standard dose of daunorubicin or twice…”
    Get full text
    Journal Article
  10. 10

    Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time? by Lazarus, Hillard M, Ragsdale, Carolyn E, Gale, Robert Peter, Lyman, Gary H

    Published in Frontiers in immunology (17-08-2021)
    “…Sargramostim [recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF)] was approved by US FDA in 1991 to accelerate bone marrow…”
    Get full text
    Journal Article
  11. 11

    Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998) by Loughran, T P, Zickl, L, Olson, T L, Wang, V, Zhang, D, Rajala, H L M, Hasanali, Z, Bennett, J M, Lazarus, H M, Litzow, M R, Evens, A M, Mustjoki, S, Tallman, M S

    Published in Leukemia (01-04-2015)
    “…Failure to undergo activation-induced cell death due to global dysregulation of apoptosis is the pathogenic hallmark of large granular lymphocyte (LGL)…”
    Get full text
    Journal Article
  12. 12

    Reconstructing fungal natural product biosynthetic pathways by Lazarus, C M, Williams, K, Bailey, A M

    Published in Natural product reports (01-10-2014)
    “…Large scale fungal genome sequencing has revealed a multitude of potential natural product biosynthetic pathways that remain uncharted. Here we describe some…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century by Ustun, C, Lazarus, H M, Weisdorf, D

    Published in Bone marrow transplantation (Basingstoke) (01-11-2013)
    “…AML treatment presents significant challenges in the elderly, who more often have poor risk cytogenetic and molecular markers, comorbidities and compromised…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? by BATTS, E. D, LAZARUS, H. M

    Published in Bone marrow transplantation (Basingstoke) (01-10-2007)
    “…Transplantation-associated thrombotic microangiopathy (TA-TMA) is an infrequent but devastating syndrome that occurs in allogeneic hematopoietic stem cell…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Genetic, molecular, and biochemical basis of fungal tropolone biosynthesis by Davison, Jack, al Fahad, Ahmed, Cai, Menghao, Song, Zhongshu, Yehia, Samar Y, Lazarus, Colin M, Bailey, Andrew M, Simpson, Thomas J, Cox, Russell J

    “…A gene cluster encoding the biosynthesis of the fungal tropolone stipitatic acid was discovered in Talaromyces stipitatus (Penicillium stipitatum) and…”
    Get full text
    Journal Article